FPHAX Holdings Information

FPHAX is a mutual fund with a total of 57 individual holdings. The top holdings are Eli Lilly and Company stock at 24.58%, GSK plc at 9.74%, Johnson & Johnson at 6.50%, Fidelity Cash Central Fund at 5.56%, and Merck & Co. at 5.50%.

Total Holdings

Top 10 Percentage

74.96%

Asset Class

Equity

Fund Category

Health

Assets

1.39B

Forward PE Ratio

17.15

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	24.58%	375,201
2	GSK	GSK plc	9.74%	2,477,060
3	JNJ	Johnson & Johnson	6.50%	373,500
4	n/a	Fidelity Cash Central Fund	5.56%	78,085,263
5	MRK	Merck & Co., Inc.	5.50%	642,336
6	EBR: UCB	UCB SA	5.09%	237,200
7	LON: AZN	AstraZeneca PLC	4.83%	343,650
8	SWX: ROP	Roche Holding AG	4.62%	162,670
9	GILD	Gilead Sciences, Inc.	4.45%	448,100
10	ELAN	Elanco Animal Health Incorporated	4.09%	2,399,200
11	JAZZ	Jazz Pharmaceuticals plc	3.28%	243,300
12	LEGN	Legend Biotech Corporation	3.25%	2,522,300
13	RPRX	Royalty Pharma plc	2.46%	718,900
14	MRNA	Moderna, Inc.	1.83%	506,100
15	VTRS	Viatris Inc.	1.66%	1,729,600
16	BNTX	BioNTech SE	1.08%	170,453
17	XENE	Xenon Pharmaceuticals Inc.	0.94%	226,000
18	PTCT	PTC Therapeutics, Inc.	0.88%	181,600
19	OCUL	Ocular Therapeutix, Inc.	0.80%	1,331,717
20	BEAM	Beam Therapeutics Inc.	0.70%	415,400
21	STO: SOBI	Swedish Orphan Biovitrum AB (publ)	0.51%	170,200
22	KYMR	Kymera Therapeutics, Inc.	0.50%	84,500
23	CAPR	Capricor Therapeutics, Inc.	0.50%	231,300
24	PAHC	Phibro Animal Health Corporation	0.49%	125,200
25	AXSM	Axsome Therapeutics, Inc.	0.48%	40,100

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026